Treatment Study for the Mycosis Fungoides Form of Cutaneous T-Cell Lymphoma

Clinical Trial Title

A double blind, randomized, vehicle controlled, crossover study to evaluate the safety and efficacy of a topical lotion, for the relief of pruritus in patients with the mycosis fungoides (MF) form of cutaneous T-cell lymphoma (CTCL).

Clinical Trial Protocol Description:

Rush Dermatology seeks volunteers with a diagnosis of the mycosis fungoides (MF) form of cutaneous T-cell lymphoma (CTCL)
for a clinical trial testing an investigational medication. All office visits and treatments are provided free of charge.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Are at least 21 years  of age or older.
  • Have a diagnosis of MF based on a combination of histological, clinical, and immunophenotypical criteria. The histological criteria will be based on skin biopsy from the most representative skin area. The diagnostic criteria used for each subject will be specified in the case report forms. The TNMB system will be used to classify the stage of disease 
  • Have a history of pruritis.
  • Have completed the mSWAT assessment.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Michael D. Tharp, MD

Contact Information

Rush Cancer Center Clinical Trials Office